Acta Neuropathologica Communications (Mar 2021)

TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6

  • Erik M. Lehmkuhl,
  • Suvithanandhini Loganathan,
  • Eric Alsop,
  • Alexander D. Blythe,
  • Tina Kovalik,
  • Nicholas P. Mortimore,
  • Dianne Barrameda,
  • Chuol Kueth,
  • Randall J. Eck,
  • Bhavani B. Siddegowda,
  • Archi Joardar,
  • Hannah Ball,
  • Maria E. Macias,
  • Robert Bowser,
  • Kendall Van Keuren-Jensen,
  • Daniela C. Zarnescu

DOI
https://doi.org/10.1186/s40478-021-01148-z
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 21

Abstract

Read online

Abstract Amyotrophic lateral sclerosis (ALS) is a genetically heterogeneous neurodegenerative disease in which 97% of patients exhibit cytoplasmic aggregates containing the RNA binding protein TDP-43. Using tagged ribosome affinity purifications in Drosophila models of TDP-43 proteinopathy, we identified TDP-43 dependent translational alterations in motor neurons impacting the spliceosome, pentose phosphate and oxidative phosphorylation pathways. A subset of the mRNAs with altered ribosome association are also enriched in TDP-43 complexes suggesting that they may be direct targets. Among these, dlp mRNA, which encodes the glypican Dally like protein (Dlp)/GPC6, a wingless (Wg/Wnt) signaling regulator is insolubilized both in flies and patient tissues with TDP-43 pathology. While Dlp/GPC6 forms puncta in the Drosophila neuropil and ALS spinal cords, it is reduced at the neuromuscular synapse in flies suggesting compartment specific effects of TDP-43 proteinopathy. These findings together with genetic interaction data show that Dlp/GPC6 is a novel, physiologically relevant target of TDP-43 proteinopathy.

Keywords